Regulation of ovarian function in obese women: pathogenetic mechanisms

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Considering the universally high rates of obesity among the population, including women of reproductive age, and the negative impact of obesity on female fertility, the interest in this problem in the modern world becomes understandable. Many researchers have confirmed the pattern of ovulatory dysfunction development because of metabolic disorders in obese women. The exact mechanism for the development of anovulation and infertility in women with obesity has not been established, however, many pathogenetic factors that affect reproductive function are already known. Obese women have a high risk of developing ovulatory dysfunction due to insulin resistance, hyperandrogenism, as well as subclinical inflammation, lipotoxicity, and disruption of adipokines due to excess adipose tissue, which generally leads to impaired steroidogenesis and regulation in the hypothalamic – pituitary – gonadal axis. Due to the high prevalence of obesity in women of reproductive age, the objective of this review was to examine the pathogenetic mechanisms of the impact of obesity on female fertility, as well as the impact of high body mass index on the results of assisted reproductive technology (ART) cycles. We carried out a literature search in the PubMed database for the entire period of publications using phrases such as “ovarian function + obesity,” “pathogenesis of ovarian dysfunction in obesity,” “ART + obesity,” and “perinatal outcomes + bariatric surgery”. The most relevant studies being selected, with domestic and foreign clinical recommendations used in preparing the manuscript.

Full Text

Restricted Access

About the authors

Albina I. Abdusalamova

Almazov National Medical Research Centre

Email: abdusalamova.albina2016@gmail.com
ORCID iD: 0000-0002-3600-990X
SPIN-code: 4831-5392
Russian Federation, Saint Petersburg

Ofelia A. Bettikher

Almazov National Medical Research Centre; The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Author for correspondence.
Email: ophelia.bettikher@gmail.com
ORCID iD: 0000-0002-1161-1558
SPIN-code: 4398-3964

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg; Saint Petersburg

Kseniia A. Rudenko

Almazov National Medical Research Centre

Email: xeniaruru@yandex.ru
ORCID iD: 0000-0001-8498-7938
SPIN-code: 3534-4785
Russian Federation, Saint Petersburg

Olga A. Belyaeva

Almazov National Medical Research Centre

Email: belyaevaolga0138@gmail.com
ORCID iD: 0000-0002-6970-7085
Russian Federation, Saint Petersburg

Aleksandr E. Neimark

Almazov National Medical Research Centre

Email: sas_spb@mail.ru
ORCID iD: 0000-0003-4925-0126
SPIN-code: 6554-3217

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg

Irina E. Zazerskaya

Almazov National Medical Research Centre; The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: zazera@mail.ru
ORCID iD: 0000-0003-4431-3917
SPIN-code: 5683-6741

MD, Dr. Sci. (Medicine)

Russian Federation, Saint Petersburg; Saint Petersburg

References

  1. Dedov II, Shestakova MV, Melnichenko GA, et al. Interdisciplinary clinical practice guidelines “Management of obesity and its comorbidities”. Obesity and metabolism. 2021;18(1):5–99. EDN: AHSBSE doi: 10.14341/omet12714
  2. Ministry of Health of the Russian Federation, Russian Association of Endocrinologists, Society of Bariatric Surgeons. Obesity. Clinical guidelines. 2020 [cited 2023 Sept 13]. Available from: https://edu.endocrincentr.ru/sites/default/files/recommendation_pdf/kr28.pdf
  3. Rosstat. Selective monitoring of the population’s diet in 2018 [cited 2023 Sept 13]. Available from: https://rosstat.gov.ru/storage/mediabank/Racion.pdf
  4. Heslehurst N, Vieira R, Hayes L, et al. Maternal body mass index and post-term birth: a systematic review and meta-analysis. Obes Rev. 2017;18(3):293–308. doi: 10.1111/obr.12489
  5. Wei S, Schmidt MD, Dwyer T, et al. Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin. Obesity (Silver Spring). 2009;17(5):1070–1076. doi: 10.1038/oby.2008.641
  6. Wise MR, Gill P, Lensen S, et al. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women. Am J Obstet Gynecol. 2016;215(5):598.e1–598.e8. doi: 10.1016/j.ajog.2016.06.006
  7. Podzolkova NM, Koloda YuA, Podzolkov AV. Infertility therapy in obese patients: modern trends. Russian Journal of Human Reproduction. 2012;18(3):37–41. EDN: PEKCFN
  8. Rich-Edwards JW, Goldman MB, Willett WC, et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994;171(1):171–177. doi: 10.1016/0002-9378(94)90465-0
  9. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148–1159. doi: 10.1111/j.1471-0528.2006.00990.x
  10. Siddiqui A, Azria E, Howell EA, Deneux-Tharaux C; EPIMOMS Study Group. Associations between maternal obesity and severe maternal morbidity: findings from the French EPIMOMS population-based study. Paediatr Perinat Epidemiol. 2019;33(1):7–16. doi: 10.1111/ppe.12522
  11. García-Ferreyra J, Carpio J, Zambrano M, et al. Overweight and obesity significantly reduce pregnancy, implantation, and live birth rates in women undergoing in vitro fertilization procedures. JBRA Assist Reprod. 2021;25(3):394–402. doi: 10.5935/1518-0557.20200105
  12. Eapen A, Hayes ET, McQueen DB, et al. Mean differences in maternal body mass index and recurrent pregnancy loss: a systematic review and meta-analysis of observational studies. Fertil Steril. 2021;116(5):1341–1348. doi: 10.1016/j.fertnstert.2021.06.019
  13. Mahutte N, Kamga-Ngande C, Sharma A, et al. Obesity and reproduction. J Obstet Gynaecol Can. 2018;40(7):950–966. doi: 10.1016/j.jogc.2018.04.030
  14. Andreeva EN, Sheremetyeva EV, Fursenko VA. Obesity — threat to the reproductive potential of Russia. Obesity and metabolism. 2019;16(3):20–28. EDN: SNJRHQ doi: 10.14341/omet10340
  15. Kabiru W, Raynor BD. Obstetric outcomes associated with increase in BMI category during pregnancy. Am J Obstet Gynecol. 2004;191(3):928–932. doi: 10.1016/j.ajog.2004.06.051
  16. Crane JM, Murphy P, Burrage L, Hutchens D. Maternal and perinatal outcomes of extreme obesity in pregnancy. J Obstet Gynaecol Can. 2013;35(7):606–611. doi: 10.1016/S1701-2163(15)30879-3
  17. Marshalov DV, Shifman EM, Salov IA, et al. Obesity as a risk factor for massive postpartum hemorrhage. Russian Journal of Anesthesiology and Reanimatology. 2016;61(4):283–289. EDN: WKNOZZ doi: 10.18821/0201-7563-2016-61-4-283-289
  18. Kan NI, Fedorina TA, Nikolaeva-Ball DR, et al. Functional state of fetoplacental complex in pregnant women with obesity and metabolic syndrome. Ulyanovsk Medico-biological Journal. 2017;(3):71–81. EDN: ZGZREH doi: 10.23648/UMBJ.2017.27.7078
  19. van der Steeg JW, Steures P, Eijkemans MJ, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008;23(2):324–328. doi: 10.1093/humrep/dem371
  20. Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity’s impact. Fertil Steril. 2017;107(4):840–847. doi: 10.1016/j.fertnstert.2017.01.017
  21. Wang YC, McPherson K, Marsh T, et al. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815–825. doi: 10.1016/S0140-6736(11)60814-3
  22. Fedorcsák P, Dale PO, Storeng R, et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod. 2004;19(11):2523–2528. doi: 10.1093/humrep/deh485
  23. Provost MP, Acharya KS, Acharya CR, et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008–2010 Society for Assisted Reproductive Technology registry. Fertil Steril. 2016;105(3):663–669. doi: 10.1016/j.fertnstert.2015.11.008
  24. Maged AM, Fahmy RM, Rashwan H, et al. Effect of body mass index on the outcome of IVF cycles among patients with poor ovarian response. Int J Gynaecol Obstet. 2019;144(2):161–166. doi: 10.1002/ijgo.12706
  25. Banker M, Sorathiya D, Shah S. Effect of body mass index on the outcome of in-vitro fertilization/intracytoplasmic sperm injection in women. J Hum Reprod Sci. 2017;10(1):37–43. doi: 10.4103/jhrs.JHRS_75_16
  26. Druzhinina AS, Vitiazeva II, Dimitrova DA. Correlation of in vitro fertilization (IVF) infertility treatment outcomes and body weight index in women of reproductive age. Problems of Endocrinology. 2021;67(1):76–82. EDN: BKYROD doi: 10.14341/probl12727
  27. Insogna IG, Lee MS, Reimers RM, et al. Neutral effect of body mass index on implantation rate after frozen-thawed blastocyst transfer. Fertil Steril. 2017;108(5):770–776.e1. doi: 10.1016/j.fertnstert.2017.08.024
  28. Mathew H, Castracane VD, Mantzoros C. Adipose tissue and reproductive health. Metabolism. 2018;86:18–32. doi: 10.1016/j.metabol.2017.11.006
  29. Dubinskaya ED, Aleshkina EV, Gasparov AS, et al. Obesity and fertility. Problems of Gynecology, Obstetrics and Perinatology. 2018;17(6):76–84. EDN: YUGSLJ doi: 10.20953/1726-1678-2018-6-76-84
  30. Estienne A, Bongrani A, Reverchon M, et al. Involvement of novel adipokines, chemerin, visfatin, resistin and apelin in reproductive functions in normal and pathological conditions in humans and animal models. Int J Mol Sci. 2019;20(18):4431. doi: 10.3390/ijms20184431
  31. Elagin IB, Orazov MR, Kharnas SS, et al. The pathogenesis of reproductive disorders in women suffering from morbid obesity. Moscow Surgical Journal. 2019;(2):43–52. EDN: NLPBWV doi: 10.17238/issn2072-3180.2019.2.43-52
  32. Petrus P, Rosqvist F, Edholm D, et al. Saturated fatty acids in human visceral adipose tissue are associated with increased 11-β-hydroxysteroid-dehydrogenase type 1 expression. Lipids Health Dis. 2015;14:42. doi: 10.1186/s12944-015-0042-1
  33. Giviziez CR, Sanchez EG, Approbato MS, et al. Obesity and anovulatory infertility: a review. JBRA Assist Reprod. 2016;20(4):240–245. doi: 10.5935/1518-0557.20160046
  34. Gambineri A, Laudisio D, Marocco C, et al. Female infertility: which role for obesity? Int J Obes Suppl. 2019;9(1):65–72. doi: 10.1038/s41367-019-0009-1
  35. Zhao H, Zhou L, Shangguan AJ, et al. Aromatase expression and regulation in breast and endometrial cancer. J Mol Endocrinol. 2016;57(1):R19–R33. doi: 10.1530/JME-15-0310
  36. Gorbatenko NV, Bezhenar VF, Fishman MB. Obesity and reproductive health of women. Obesity and metabolism. 2017;14(1):3–8. EDN: YRUSJB doi: 10.14341/omet201713-8
  37. Isaeva AP, Gapparova KM, Chekhonina YuG., et al. Characteristics of free fatty acid metabolism in pathogenesis of obesity: current view. Problems of Nutrition. 2018;87(1):18–27. EDN: YRZCFQ doi: 10.24411/0042-8833-2018-10002
  38. Liu R, Nikolajczyk BS. Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front Immunol. 2019;10:1587. doi: 10.3389/fimmu.2019.01587
  39. Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017;127(1):74–82. doi: 10.1172/JCI88883
  40. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–1830. doi: 10.1172/jci200319451
  41. Kolb H, Stumvoll M, Kramer W, et al. Insulin translates unfavourable lifestyle into obesity. BMC Med. 2018;16(1):232. doi: 10.1186/s12916-018-1225-1
  42. Williams KJ, Wu X. Imbalanced insulin action in chronic over nutrition: clinical harm, molecular mechanisms, and a way forward. Atherosclerosis. 2016;247:225–282. doi: 10.1016/j.atherosclerosis.2016.02.004
  43. Aganezova NV, Aganezov SS. Obesity and female reproductive health. Obstetrics and Gynecology. 2016;(6):18–25. EDN: WGAYHF doi: 10.18565/aig.2016.6.18-25
  44. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800. doi: 10.1210/edrv.18.6.0318
  45. Dedov II, Melnichenko GA, Andreeva EN, et al. Polycystic ovary syndrome. Moscow: Medical Information Agency; 2007. 368 p. EDN: TSFPRP (In Russ.)
  46. Demidova TYu, Gritskevich EYu. Role of obesity in development of reproductive disorders and possibilities of risk management. RMJ. 2018;26(11–2):105–109. EDN: YOCINV
  47. Liu Z, Wang Z, Hao C, et al. Effects of ADIPOQ polymorphisms on PCOS risk: a meta-analysis. Reprod Biol Endocrinol. 2018;16(1):120. doi: 10.1186/s12958-018-0439-6
  48. Panidis D, Tziomalos K, Misichronis G, et al. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod. 2012;27(2):541–549. doi: 10.1093/humrep/der418
  49. Ding H, Zhang J, Zhang F, et al. Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12. doi: 10.3389/fendo.2021.741764
  50. Sermondade N, Huberlant S, Bourhis-Lefebvre V, et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):439–451. doi: 10.1093/humupd/dmz011
  51. Zhao Z, Jiang X, Li J, et al. The combined impact of female and male body mass index on cumulative pregnancy outcomes after the first ovarian stimulation. Front Endocrinol (Lausanne). 2021;12. doi: 10.3389/fendo.2021.735783
  52. Xiong Y, Wang J, Huang S, et al. Association between maternal prepregnancy body mass index and pregnancy outcomes following assisted reproductive technology: a systematic review and dose-response meta-analysis. Obes Rev. 2021;22(6). doi: 10.1111/obr.13219
  53. Toftager M, Bogstad J, Løssl K, et al. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Hum Reprod. 2017;32(3):556–567. doi: 10.1093/humrep/dew358
  54. Mitchell GW, Rogers J. The influence of weight reduction on amenorrhea in obese women. N Engl J Med. 1953;249(21):835–837. doi: 10.1056/NEJM195311192492102
  55. Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Russian Journal of Cardiology. 2020;25(4):101–161. (In Russ.) EDN: CJIJDF doi: 10.15829/1560-4071-2020-3839
  56. Brown RCH. Irresponsibly infertile? Obesity, Efficiency, and exclusion from treatment. Health Care Anal. 2019;27(2):61–76. doi: 10.1007/s10728-019-00366-w
  57. Dedov II, Melnichenko GA, Shestakova MV, et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (morbid obesity treatment in adults). Obesity and metabolism. 2018;15(1):53–70. EDN: OUJNNF doi: 10.14341/omet2018153-70
  58. Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures — 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists — executive summary. Endocr Pract. 2019;25(12):1346–1359. doi: 10.4158/GL-2019-0406
  59. Kwong W, Tomlinson G, Feig DS. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks? Am J Obstet Gynecol. 2018;218(6):573–580. doi: 10.1016/j.ajog.2018.02.003
  60. Parent B, Martopullo I, Weiss NS, et al. Bariatric surgery in women of childbearing age, timing between an operation and birth, and associated perinatal complications. JAMA Surg. 2017;152(2):128–135. doi: 10.1001/jamasurg.2016.3621
  61. Akhter Z, Rankin J, Ceulemans D, et al. Pregnancy after bariatric surgery and adverse perinatal outcomes: a systematic review and meta-analysis. PLoS Med. 2019;16(8). doi: 10.1371/journal.pmed.1002866
  62. Saif T, Strain GW, Dakin G, et al. Evaluation of nutrient status after laparoscopic sleeve gastrectomy 1, 3, and 5 years after surgery. Surg Obes Relat Dis. 2012;8(5):542–547. doi: 10.1016/j.soard.2012.01.013

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Eсо-Vector

License URL: https://eco-vector.com/for_authors.php#07

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.